Atlas Trials

A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

Clinical trial NCT01867125 · COMPLETED

Trial details

NCT number
NCT01867125
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2013-07-25
Primary completion
2016-12-28
Enrollment
1081

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.